D. Vijay Pharma Private Limited
D. Vijay Pharma Private Limited
Send Email
0804895547968% Response Rate
Search

Home » Our Products » Covid-19 Antigen Test & Medicine


Covid-19 Antigen Test & Medicine

Wholesaler of a wide range of products which include molnupiravir 200mg capsule, mylab antigen test kits, covifor 100 mg injection and remdesvir redyx 100mg injection.

Molnupiravir 200mg Capsule

REQUEST CALLBACK

Molnupiravir  200mg Capsule
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1,650 / BottleGet Latest Price

Product Details:
Minimum Order Quantity1 Bottle
Packaging SizeBottle
Strength200Mg
Compositionmolnupiravir
Treatmentcovid 19 treatment
Prescription/Non prescriptionPrescription
Brandmolnunat 200
Manufacturernatco ltd

Molnupiravir, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action through introduction of copying errors during viral RNA replication.
Yes! I am interested

Mylab Antigen Test Kits

REQUEST CALLBACK

Mylab Antigen Test Kits
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 120 / UnitGet Latest Price

Product Details:
Minimum Order Quantity10 Unit
Number of Reactions(Preps)/Kit1
Number of Reactions1
Brandcoviself test kit
ICMR ApprovedYes
Test MethodAntigen Test
Result Time (Rapid Kits)20 minutes
Sample TypeNasal Swab

Is COVID-19 rapid antigen test accurate? Rapid antigen tests are highly specific, which means that they generate relatively few false positives. However, a positive result is more likely to be a false positive when the prevalence of the virus is low; in these instances, people may want to take a second test.
Yes! I am interested

Covifor 100 Mg Injection

REQUEST CALLBACK

Covifor 100 Mg Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1,400 / VialGet Latest Price

Product Details:
Minimum Order Quantity5 Vial
Packaging Size20 ml
Strength100 Mg
CompositionRemdesivir Inj
TreatmentTo treat coronavirus infection
Prescription/Non prescriptionPrescription
FormInjection
BrandCovifor Injection
ManufacturerMylan
Shelf life1 Year

Remdesivir (Covifor) was the first drug approved by the FDA for treating the SARS-CoV-2 virus. It is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older who weigh at least 40 kg. The broad-spectrum antiviral is a nucleotide analog prodrug. Full approval was preceded by the US FDA issuing an EUA (emergency use authorization) on May 1, 2020 to allow prescribing remdesivir for severe COVID-19 (confirmed or suspected) in hospitalized adults and children. Upon approval of remdesivir in adults and adolescents, the EUA was updated to maintain the ability for prescribers to treat pediatric patients weighing 3.5 kg to less than 40 kg or children younger than 12 years who weigh at least 3.5 kg.

Remdesivir is given by injection into a vein usually once daily for 5 to 10 days. It is infused over a period ranging from 30 minutes to 2 hours.

The length of treatment depends on your medical condition, response to treatment, and the study guidelines.

An infusion reaction may occur with remdesivir with symptoms such as low or high blood pressure, dizziness, slow/fast heartbeat, fever, nausea, vomiting, sweating, and shivering. A slower rate of infusion may help to lessen the risk of this reaction. The healthcare professional should monitor for side effects during remdesivir treatment.

Information is limited and it is unknown at this time if remdesivir causes serious side effects.

 

In the case of a serious allergic reaction, symptoms may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

Yes! I am interested

Remdesvir Redyx 100Mg Injection

REQUEST CALLBACK

Remdesvir Redyx 100Mg Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1,400 / VialGet Latest Price

Product Details:
Minimum Order Quantity5 Vial
Packaging Size20 Ml
BrandRedyx L
ManufacturerDr.Reddys
CompositionRemedisivir
TreatmentFor SARS-CoV-2 virus
Prescription/Non prescriptionPrescription
FormInjection
Shelf life1Year
Country of OriginMade in India

Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.
Remdesivir injection may cause serious reactions during and after the infusion of the medication. A doctor or nurse will monitor you carefully while you are receiving the medication. Tell your doctor or nurse immediately if you experience any of the following symptoms during or after the infusion: chills or shivering; nausea; vomiting; sweating; dizziness upon standing up; rash; wheezing or shortness of breath; abnormally fast or slow heartbeat; or swelling of the face, throat, tongue, lips, or eyes. Your doctor may need to slow down your infusion or stop your treatment if you experience these side effects.
The FDA has approved an Emergency Use Authorization (EUA) to allow children weighing 8 pounds (3.5 kg) to less than 88 pounds (40 kg) or children less than 12 years of age weighing at least 8 pounds (3.5 kg) who are hospitalized with severe COVID-19 to receive remdesivir.

Remdesivir may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
  • nausea
  • pain, bleeding, bruising of the skin, soreness, or swelling near the place where the medication was injected
Some side effects can be serious. If you experience any of these symptoms or those in the HOW section, call your doctor immediately or get emergency medical treatment:
  • yellow eyes or skin; dark urine; or pain or discomfort in right upper stomach area
Yes! I am interested

 
X


Explore More Products

Contact via E-mail
Contact via SMS
SANTOSH CHAMOLI (Marketing Manager)
D. Vijay Pharma Private Limited
Unit No. 11, Shilpin Center, GD Ambedkar Road
Mumbai - 420031, Maharashtra, India
Call Us: 
Call Response Rate: 68%
Share Us :



Home  |   Profile   |  Our Products  |  Site Map  |   Contact Us

© D. Vijay Pharma Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

D. Vijay Pharma Private Limited